Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEMS Adherence Study for Tecfidera in MS
NCT02343159Phase 4Terminated
- Sponsor
- Biogen
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Biogen. Primary endpoint: Overall Adherence Rates at 12 months. Started Feb 2015; status: terminated.
Beyond the preview
Go deeper on NCT02343159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343159.